Appointment booking for Dr. Manas Agastya, MD is currently not available.Dr. Manas Agastya, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Manas Agastya, MD (he/him) is a Internist in Las Vegas, NV with over 10 years of experience. What is your opinion of Dr. Manas Agastya, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 10 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Manas Agastya, MD has received over $2,436 which includes payments from the following companies:
$610.22 from Astellas Pharma US Inc
$532.63 from Amgen Inc.
$216.94 from Incyte Corporation
$129.96 from Seattle Genetics, Inc.
$123.95 from Takeda Pharmaceuticals U.S.A., Inc.
$116.88 from Bayer HealthCare Pharmaceuticals Inc.
$86.46 from Pfizer Inc.
$81.70 from Janssen Biotech, Inc.
$79.78 from Alexion Pharmaceuticals, Inc.
$53.08 from Merck Sharp & Dohme Corporation
$50.78 from Celgene Corporation
$48.88 from Verastem, Inc.
$44.84 from Jazz Pharmaceuticals Inc.
$42.11 from Taiho Oncology, Inc.
$29.34 from Janssen Pharmaceuticals, Inc
$29.10 from GENZYME CORPORATION
$23.18 from Rigel Pharmaceuticals, Inc.
$21.00 from Ipsen Biopharmaceuticals, Inc
$19.55 from AbbVie, Inc.
$18.15 from Stemline Therapeutics Inc.
Payments received by Dr. Manas Agastya, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!